Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Factors associated with clinically significant increased walking time in multiple sclerosis: Results of a survival analysis of short-term follow-up data from a clinical database.
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity.
Longitudinally extensive optic neuritis in neuromyelitis optica spectrum disorder.
Blood cells and endothelial barrier function.
Clinical significance of the number of oligoclonal bands in patients with clinically isolated syndromes.
Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis.
Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators.
Ipsilateral uveitis and optic neuritis in multiple sclerosis.
Evidence of extensive RNA oxidation in normal appearing cortex of multiple sclerosis brain.
Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.
Targeting ion channels for the treatment of autoimmune neuroinflammation.
Genome-wide association studies: will we ever predict susceptibility to multiple sclerosis through genetics?
[White matter lesions, young age, female - differential diagnosis of multiple sclerosis and juvenile stroke].
Role of intravenous immunoglobulin in the treatment of acute relapses of neuromyelitis optica: experience in 10 patients.
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Introduction: occupational therapy practice and research with persons with multiple sclerosis.
Assessing the Correlation between Grey and White Matter Damage with Motor and Cognitive Impairment in Multiple Sclerosis Patients.
Management of fatigue in persons with multiple sclerosis.
Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.
Relapsing multiple sclerosis patients can look to second oral agent.
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis.
Trial and error in clinical studies: lessons from ATAMS.
Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis.
Monitoring technology for wheelchair users with advanced multiple sclerosis.
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review.
Pages
« first
‹ previous
…
396
397
398
399
400
401
402
403
404
…
next ›
last »